Cargando…

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients With Atrial Fibrillation

BACKGROUND: This study aimed to investigate the prevalence and factors associated with the initiation of oral anticoagulation among patients with acute ischemic stroke (AIS) and concurrent atrial fibrillation (AF) at discharge in China. METHODS: We continuously included hospitalized patients with AI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Xiaoxian, Chen, Hongfang, Wang, Jianan, Zhong, Wansi, Chen, Luowei, Yan, Shenqiang, Lou, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005870/ https://www.ncbi.nlm.nih.gov/pubmed/35433893 http://dx.doi.org/10.3389/fcvm.2022.841020

Ejemplares similares

Prediction of Acute Myocardial Infarction in Asian Patients With Acute Ischemic Stroke: The CTRAN Score
por: Chen, Luowei, et al.
Publicado: (2022)

Associations of lipid profiles with the risk of ischemic and hemorrhagic stroke: A systematic review and meta-analysis of prospective cohort studies
por: Gong, Xiaoxian, et al.
Publicado: (2022)

Endovascular Treatment for Minor Acute Ischemic Strokes With Large Vessel Occlusion
por: Xue, Rui, et al.
Publicado: (2022)

Causative Classification of Ischemic Stroke by the Machine Learning Algorithm Random Forests
por: Wang, Jianan, et al.
Publicado: (2022)

Long-Term Efficacy and Anticoagulation Strategy of Left Atrial Appendage Occlusion During Total Thoracoscopic Ablation of Atrial Fibrillation to Prevent Ischemic Stroke
por: Kim, Ju Youn, et al.
Publicado: (2022)

Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
por: Hsu, Jin-Yi, et al.
Publicado: (2022)

Association of Proton Pump Inhibitor Prophylaxis on Clinical Outcome in Acute Ischemic Stroke in China: A Multicenter Retrospective Cohort Study
por: Fang, Lei, et al.
Publicado: (2022)

Undertreatment or Overtreatment With Statins: Where Are We?
por: García-Fernández-Bravo, Irene, et al.
Publicado: (2022)

Association Between Apelin and Atrial Fibrillation in Patients With High Risk of Ischemic Stroke
por: Bohm, Allan, et al.
Publicado: (2021)

Anticoagulation therapy in patients with stroke and atrial fibrillation: a registry-based study of acute stroke care in Surrey, UK
por: Han, Thang S, et al.
Publicado: (2018)

Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation
por: Zawawi, Nur Azyyati, et al.
Publicado: (2021)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
por: Choi, Ju Hee, et al.
Publicado: (2022)

Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
por: Li, Wenhao, et al.
Publicado: (2022)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
por: Li, Runkai, et al.
Publicado: (2023)

Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
por: Adelakun, Adenike R, et al.
Publicado: (2023)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

Temporal trends in anticoagulation management for US active duty personnel with atrial fibrillation
por: Keithler, Andrea Nichole, et al.
Publicado: (2022)

Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023)

Is the Risk of Diabetes Lower in Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulant Compared to Warfarin?
por: Liu, Xuyang, et al.
Publicado: (2022)

Stroke risk evaluation for patients with atrial fibrillation: Insights from left atrial appendage
por: Fang, Runxin, et al.
Publicado: (2022)

Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study
por: Chen, Pei-Ti, et al.
Publicado: (2019)

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States
por: Deitelzweig, Steven, et al.
Publicado: (2020)

Evaluating the Risk of Paroxysmal Atrial Fibrillation in Noncardioembolic Ischemic Stroke Using Artificial Intelligence-Enabled ECG Algorithm
por: Han, Changho, et al.
Publicado: (2022)

Evaluation of anticoagulation status for atrial fibrillation on early ischaemic stroke outcomes: a registry-based, prospective cohort study of acute stroke care in Surrey, UK
por: Han, Thang S, et al.
Publicado: (2017)

Contemporary survival and anticoagulation of patients with atrial fibrillation: A community based cohort study in China
por: Wei, Yong, et al.
Publicado: (2022)

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation
por: Fox, Keith A A, et al.
Publicado: (2017)

Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study
por: Lunde, Elin Danielsen, et al.
Publicado: (2021)

Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care
por: Harris, K, et al.
Publicado: (2013)

Not Baseline Atrial Fibrillation but New-Onset Atrial Fibrillation and the Loss of Left Atrial Function Are Essential for Predicting Poor Outcomes in Non-ischemic Cardiomyopathy
por: Okune, Mana, et al.
Publicado: (2021)

Predicting ischemic stroke risk from atrial fibrillation based on multi-spectral fundus images using deep learning
por: Li, Hui, et al.
Publicado: (2023)

Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study
por: MacCallum, Peter K, et al.
Publicado: (2013)

A New Vision at the Interface of Atrial Fibrillation and Stroke
por: Ronsoni, Rafael M., et al.
Publicado: (2021)

Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
por: Lin, Dong, et al.
Publicado: (2021)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
por: Grymonprez, Maxim, et al.
Publicado: (2022)

Meta-Analysis of Oral Anticoagulants and Adverse Outcomes in Atrial Fibrillation Patients After Intracranial Hemorrhage
por: Liu, Xin, et al.
Publicado: (2022)

Effect of direct oral anticoagulants in patients with atrial fibrillation with mitral or aortic stenosis: A review
por: Guo, Guigao, et al.
Publicado: (2022)

Mitral Regurgitation and Body Mass Index Increase the Predictability of Perioperative Bleeding in Anticoagulated Patients With Nonvalvular Atrial Fibrillation
por: Huang, Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8l5ihspqll7gk048sfsakt7g30